Canada Spends Logo

Explorez notre analyse du budget 2026

Contribution: New Building Canada Fund-Provincial-Territorial Infrastructure Component-National and Regional Projects

Triumf | Triumf

$10,232,310.00

The Institute for Advanced Medical Isotopes

EF 2018-19 · 2018-09-21

Résumé
A contribution to support the creation of the Institute for Advanced Medical Isotopes.
Programme
New Building Canada Fund-Provincial-Territorial Infrastructure Component-National and Regional ProjectsNew Building Canada Fund-Provincial-Territorial Infrastructure Component-National and Regional Projects (lien de confiance élevée)
Bénéficiaire
Emplacement
Vancouver | Vancouver, British Columbia, Canada
Type de bénéficiaire
Not-for-profit organization or charity
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

Tel que publié

Additional Information
Multi-year award for fiscal years 2018-19 to 2023-24.
Additional Information (French)
Contribution pluriannuelle pour les excercises 2018-19 à 2023-24.
Agreement End Date
2024-03-31
Agreement Start Date
2018-09-21
Agreement Title
The Institute for Advanced Medical Isotopes
Agreement Title (French)
L’Institut des isotopes médicaux avancés
Agreement Type
Contribution
Agreement Value
$10,232,310.00
Amendment Number
0
Description
A contribution to support the creation of the Institute for Advanced Medical Isotopes.
Description (French)
Une contribution pour soutenir la création de l'Institut des isotopes médicaux avancés.
Organization Code
infc
Organization
Department of Housing, Infrastructure and Communities | Ministère du Logement, de l’Infrastructure et des Collectivités
Program Name
New Building Canada Fund-Provincial-Territorial Infrastructure Component-National and Regional Projects
Program Name (French)
Nouveau Fonds Chantiers Canada-Volet infrastructures provinciales-territoriales-Projets nationaux et régionaux
Recipient City
Vancouver | Vancouver
Recipient Country
CA
Recipient Legal Name
Triumf | Triumf
Recipient Province or Territory
BC
Recipient Type
N
Reference Number
278-2018-2019-Q2-00002